** Leerink analyst Danielle Antalffy says Johnson & Johnson
 JNJ.N  seems more open to a larger-scale Medtech deal, in
context to JNJ's deal to buy Japanese skincare firm Ci:z
Holdings  4924.T 
    ** JNJ to buy all outstanding shares of Ci:z that it does
not already own, for $2.05 bln in cash  urn:newsml:reuters.com:*:nL3N1X34S2
    ** JNJ shares down 0.64 pct at $137.79
    ** Main question to Medtech investors is going to be how a
small-to-mid size deal like this will impact JNJ's appetite for
further acquisitions, particularly potential large-scale
acquisitions - Antalffy
    ** Antalffy believes JNJ could scale up, specifically in
cardiology, within the next 12-18 months
    ** Antalffy also highlights that JNJ will strengthen its
overall presence in Japan, a market estimated at more than $20
bln, through the deal

 (Reporting by Shreyashi Sanyal in Bengaluru)
 ((RM: Shreyashi.Sanyal.thomsonreuters.com@reuters.net))